Pfizer and Bristol-Myers Squibb (BMS) recently raised questions with and sought further clarity from the US Food and Drug Administration (FDA) on a draft guidance related to the risk-based monitoring ...
Welcome back and I hope you all had an amazing summer. I want to let all of your know of an amazing opportunity to get a certification in the Bureau of Land Management’s Assessment, Inventory, and ...
Following the release of five guidances to broaden cancer clinical trial eligibility earlier this week, the US Food and Drug Administration (FDA) is out with draft guidance Thursday on the risk-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results